• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Personalis (PSNL)

Common Shares
Sell: $9.15|Buy: $9.69|Change: 1.15 (-11.19%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Address




Website

https://www.personalis.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Personalis Inc Second Quarter Earnings Conference Call for 20262026-08-05T17:00:00
Personalis Inc Second Quarter Earnings Results for 20262026-08-05T00:00:00
Personalis Inc Annual General Meeting for 20262026-05-15T09:00:00
Personalis Inc First Quarter Earnings Conference Call for 20262026-05-06T17:00:00
Personalis Inc First Quarter Earnings Results for 20262026-05-06T00:00:00
Personalis Inc Fourth Quarter Earnings Conference Call for 20252026-02-27T17:00:00
Personalis Inc Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
Personalis Inc Annual Report for 20252026-02-27T00:00:00
Personalis Inc Third Quarter Earnings Conference Call for 20252025-11-06T17:00:00
Personalis Inc Third Quarter Earnings Results for 20252025-11-06T00:00:00

Previous key dates

NameKey Date
Personalis Inc Second Quarter Earnings Conference Call for 20252025-08-05T17:00:00
Personalis Inc Second Quarter Earnings Result for 20252025-08-05T00:00:00
Personalis Inc Annual General Meeting for 20252025-05-16T09:00:00
Personalis Inc First Quarter Earnings Conference Call for 20252025-05-06T17:00:00
Personalis Inc First Quarter Earnings Result for 20252025-05-06T00:00:00
TD Cowen's 45th Annual Health Care Conference2025-03-03T00:00:00
Personalis Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T17:00:00
Personalis Inc Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
Personalis Inc Annual Report for 20242025-02-27T00:00:00
Piper Sandler 36th Annual Healthcare Conference2024-12-03T12:30:00
Personalis Inc Third Quarter Earnings Conference Call for 20242024-11-06T17:00:00
Personalis Inc Third Quarter Earnings Results for 20242024-11-06T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.